Buying Alexion remains a “fantastic acquisition” for AstraZeneca, the Big Pharma’s CEO has said, even as the company takes a $753 million hit for abandoning one of the drugs from that ...

Amgen’s famously voracious legal team is living up to its reputation once again, this time with a surprise challenge on the patents surrounding Alexion’s rare diseases blockbuster, Soliris.

The suspects fled the scene and are yet to be arrested. Athlone detectives are investigating two counts of murder and one of attempted murder" ...

Last year, AstraZeneca reported that a new drug to treat Wilson disease developed by its Alexion rare diseases unit had hit the mark in a phase 3 trial, setting it on course for regulatory filings.

As­traZeneca has ter­mi­nat­ed all de­vel­op­ment of vemir­co­pan, the oral fac­tor D in­hibitor it ac­quired through the deal for Alex­ion in 2021. The UK ma­jor record­ed … ...

Chevrolet arrived in the country in the mid-2000s hoping to make a name for itself by rebranding certain Opel products with the bowtie badge. The strategy didn't really fit with the local idea of what ...